PAI1 blocks effects of tissue-type plasminogen activator on cell-signaling and physiology mediated by the NMDA receptor

Author:

Gonias Steven L.1ORCID,Banki Michael A.1,Gilder Andrew S.1,Azmoon Pardis1,Campana Wendy M.2,Mantuano Elisabetta13

Affiliation:

1. Department of Pathology, University of California San Diego, La Jolla CA, 92093, USA

2. Department of Anesthesiology and the Program in Neuroscience, University of California San Diego, La Jolla CA, 92093, USA

3. Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy

Abstract

The fibrinolysis proteinase, tissue-type plasminogen activator (tPA), triggers cell-signaling and regulates cell physiology. In PC12 cells, Schwann cells, and macrophages, the N-methyl-D-aspartate receptor (NMDA-R) mediates tPA-signaling. Plasminogen activator Inhibitor-1 (PAI1) is a rapid inhibitor of tPA enzyme activity. Although tPA-initiated cell-signaling is not dependent on its enzyme active site, we show that tPA-signaling is neutralized by PAI1. In PC12 cells, PAI1 blocked ERK1/2 activation by tPA and neurite outgrowth. In Schwann cells, PAI1 blocked tPA-mediated ERK1/2 activation and cell migration. In macrophages, PAI1 blocked the ability of tPA to inhibit IκBα phosphorylation and cytokine expression. The cell-signaling activity of tPA-PAI1 complex was rescued by forming the complex with PAI1R76→E, which binds to LRP1 with decreased affinity, by pre-treating cells with the LRP1 antagonist, Receptor-associated Protein, or by LRP1 gene-silencing. The inhibitory activity of LRP1 in tPA-PAI1 complex-initiated cell-signaling was unanticipated given the reported role of LRP1 as an NMDA-R co-receptor in signaling responses elicited by free tPA or α2-macroglobulin. We conclude that PAI1 functions as an inhibitor not only of the enzyme activity of tPA but also tPA receptor-mediated activities.

Funder

National Institutes of Health

Publisher

The Company of Biologists

Subject

Cell Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3